VNA
HALO icon

Valley National Advisers’s Halozyme HALO Stock Holding History

Valley National Advisers’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-30
Closed -$1K – 909
2024
Q2 		$1K Sell
30
-5
-14% -$219 ﹤0.01% 1048
2024
Q1 		$1K Buy
+35
New +$1.31K ﹤0.01% 1086

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Valley National Advisers's HALO Position: Q3 2024 in Review

Valley National Advisers sold out of Halozyme (HALO) in Q3 2024, closing a stake of 30 shares — an estimated $1K sold.

Valley National Advisers first reported a position in HALO in Q1 2024 and held it in 2 quarters. The position peaked at $1K in Q2 2024. 508 funds tracked by Wall St. Rank hold HALO as of Q3 2024.

  • Valley National Advisers reported no remaining Halozyme position as of Q3 2024 after selling out during the quarter.
  • Valley National Advisers sold 30 Halozyme shares in Q3 2024, an estimated $1K.
  • Valley National Advisers first reported a position in Halozyme in Q1 2024 and held it in 2 quarters.
  • Valley National Advisers's Halozyme position peaked at $1K in Q2 2024.
  • 508 funds tracked by Wall St. Rank held Halozyme as of Q3 2024.

Based on Valley National Advisers's 13F filing for Q3 2024, filed 24 Oct 2024.